Advancing new cancer treatments, tests, and imaging
Clinical and Translational Oncology Program (CTOP)
This program develops and tests new cancer drugs, biomarkers, and imaging tools and runs clinical trials to help people with cancer get better, more precise care.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-11158864 on NIH RePORTER |
What this research studies
This program brings together lab scientists and clinicians to turn laboratory discoveries into treatments and scans that can be used in patients. They work on finding and optimizing new drugs, identifying biomarkers, and improving imaging techniques, then move promising approaches into investigator-initiated and other clinical trials. The program also supports reverse translation, where patient results guide new laboratory studies, and has focused work relevant to blood cancers like AML and to bone marrow transplant-related research. Activities are centered at the University of Arizona and its cancer center partners in the region.
Who could benefit from this research
Good fit: People with cancer in the University of Arizona catchment area, including those with blood cancers such as AML or those eligible for investigator-initiated trials, are the main candidates for participation.
Not a fit: People without cancer, those not eligible for the specific clinical trials due to health, prior treatments, or location, or those seeking only standard-of-care without trial options may not benefit directly.
Why it matters
Potential benefit: If successful, it could deliver new, more effective cancer therapies, earlier diagnostics, and improved imaging that reduce side effects and improve outcomes.
How similar studies have performed: Related translational programs have led to approved therapies (for example, prior work here contributed to the approval of afamelanotide) though many investigational approaches remain experimental.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Nawrocki, Steffan T — University of Arizona
- Study coordinator: Nawrocki, Steffan T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.